Belite Bio (BLTE) Share-based Compensation (2020 - 2025)

Belite Bio's Share-based Compensation history runs 4 years deep, the most recent figure standing at $11.7 million for Q4 2025.

• In Q4 2025, Share-based Compensation rose 366.59% year-over-year to $11.7 million; the TTM figure through Dec 2023 stood at $3.4 million (up 571.79% YoY), while the FY2025 annual figure was $38.9 million, up 1377.56% from the prior year.
• Share-based Compensation for Q4 2025 stood at $11.7 million, up from -$4.4 million in the prior quarter.
• The five-year high for Share-based Compensation was $11.7 million in Q4 2025, with the low at -$4.4 million in Q4 2024.
• The 4-year median for Share-based Compensation is $2.0 million (2022), against an average of $2.8 million.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation surged 571.79% in 2023, then plunged 229.01% in 2024.
• Belite Bio's Share-based Compensation stood at $507000.0 in 2022, then soared by 571.79% to $3.4 million in 2023, then slumped by 229.01% to -$4.4 million in 2024, then soared by 366.59% to $11.7 million in 2025.
• Business Quant data shows BLTE's Share-based Compensation at $11.7 million in Q4 2025, -$4.4 million in Q4 2024, and $3.4 million in Q4 2023.